TY  - THES
AB  - This study examined factors associated with retention in an opioid treatment program and explored whether continued stimulant use affected retention. Clinical data from 153 patients enrolled in a trial comparing six months of buprenorphine/naltrexone versus methadone were analyzed. A secondary analysis evaluated patient characteristics and program factors, and a Markov chain analysis assessed differences in stimulant use by treatment type. Patients on methadone, those who began treatment later in the study, attended weekly group sessions, had longer periods of abstinence in the prior year, or were not intravenous drug users showed better retention. Buprenorphine did not reduce stimulant use more effectively than methadone. Findings suggest that methadone combined with counseling supports greater treatment retention, which may lead to improved outcomes, while neither medication showed clear advantages in reducing stimulant use.
AD  - Oregon Health and Science University
AU  - Carr, Kathryn
DA  - 2010
DO  - 10.6083/M49C6VCZ
DO  - DOI
ED  - Choi, Dongseok
ED  - Advisor
ED  - Mentor
ID  - 608
KW  - Methamphetamine
KW  - Methadone
KW  - Substance-Related Disorders
KW  - Cocaine
KW  - Buprenorphine
KW  - Liver
KW  - Retention in Care
KW  - Naltrexone
KW  - Analgesics, Opioid
KW  - Substance Abuse Treatment Centers
KW  - Counseling
L1  - https://digitalcollections.ohsu.edu/record/608/files/609_etd.pdf
L2  - https://digitalcollections.ohsu.edu/record/608/files/609_etd.pdf
L4  - https://digitalcollections.ohsu.edu/record/608/files/609_etd.pdf
LK  - https://digitalcollections.ohsu.edu/record/608/files/609_etd.pdf
N2  - This study examined factors associated with retention in an opioid treatment program and explored whether continued stimulant use affected retention. Clinical data from 153 patients enrolled in a trial comparing six months of buprenorphine/naltrexone versus methadone were analyzed. A secondary analysis evaluated patient characteristics and program factors, and a Markov chain analysis assessed differences in stimulant use by treatment type. Patients on methadone, those who began treatment later in the study, attended weekly group sessions, had longer periods of abstinence in the prior year, or were not intravenous drug users showed better retention. Buprenorphine did not reduce stimulant use more effectively than methadone. Findings suggest that methadone combined with counseling supports greater treatment retention, which may lead to improved outcomes, while neither medication showed clear advantages in reducing stimulant use.
PB  - Oregon Health and Science University
PY  - 2010
T1  - Stimulant use and treatment retention among individuals in an opioid maintenance treatment program
TI  - Stimulant use and treatment retention among individuals in an opioid maintenance treatment program
UR  - https://digitalcollections.ohsu.edu/record/608/files/609_etd.pdf
Y1  - 2010
ER  -